Skip to main content

A view of the Kodak booth is seen during the 2012 International Consumer Electronics Show (CES) in Las Vegas, Nevada, Jan. 11, 2012.

STEVE MARCUS/STEVE MARCUS/REUTERS

Bankrupt camera maker Eastman Kodak Co agreed to sell its digital imaging patents for about $525-million to a consortium led by Intellectual Ventures and RPX Corp, a key step to ending its bankruptcy.

The photography pioneer said a portion of the payment will come from 12 intellectual property licensees organized by Intellectual Ventures and RPX Corporation.

A sale of the roughly 1,100 patents, which Kodak has said could be worth as much as $2.6-billion, has been a key element of the Rochester, New York-based company's plans to shift its focus to commercial packaging and printing from photography.

Story continues below advertisement

Intellectual Ventures was founded by former Microsoft executive Nathan Myhrvold to amass patents and collect license fees on the technologies. The company has been disparagingly referred to as a "patent troll" in Silicon Valley: the unflattering nickname arose due to their habit of demanding fees (with the threat of litigation) from unsuspecting businesses, much like mythical trolls that lie in wait under bridges to extract tolls from travellers.

In previous reports on the patent sale technology firms Apple Inc. and Google Inc. had allegedly led two separate consortia to buy the Kodak patents. The Apple-led group included Microsoft and Intellectual Ventures Management, while Google's consortium included RPX and Asian manufacturers of Google's Android phones, including presumably Samsung, the largest Android phone maker, as well as LG and HTC, though original reporting by Bloomberg did not identify those manufacturers by name.

The agreements are subject to approval by the U.S. Bankruptcy Court in Manhattan.

The Kodak bankruptcy case is in Re: Eastman Kodak Co. et al, U.S. Bankruptcy Court, Southern District of New York, No. 12-10202.

With files from Reuters reporter Sarah McBride

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter